Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
05/21/1996 | US5518736 Method of preparing natural-oil-containing emulsions and microcapsules and its uses |
05/21/1996 | US5518734 Transdermal delivery system for estradiol and process for manufacturing said device |
05/21/1996 | US5518733 Cosmetic compositions containing oligosaccharides |
05/21/1996 | US5518732 Bio-erodible ophthalmic shield |
05/21/1996 | US5518731 Nonaqueous fluorinated drug delivery vehicle suspensions |
05/21/1996 | US5518730 Biodegradable controlled release flash flow melt-spun delivery system |
05/21/1996 | US5518718 Nonirritating nonionic tissue cleaning compositions |
05/21/1996 | US5518716 Composition and method of preparing microemulsion blends |
05/21/1996 | US5518709 Preparation of diagnostic agents |
05/21/1996 | US5518680 Tissue regeneration matrices by solid free form fabrication techniques |
05/21/1996 | US5518551 Spheroidal crystal sugar and method of making |
05/21/1996 | US5518187 Method of grinding pharmaceutical substances |
05/21/1996 | CA2029175C Method of producing compacted dispersable systems |
05/21/1996 | CA1338344C Stabilized medicinal substances, a process for the preparation thereof, and stable medicinal formulations |
05/21/1996 | CA1338337C Method and composition for the treatment of burns |
05/17/1996 | WO1996014365A2 Process for stabilizing gelatin products |
05/17/1996 | WO1996014360A1 Epoxy ester vesicles and paints |
05/17/1996 | WO1996014292A1 Process for the purification of a non-enolisable ester with a metallic reagent selected from a metal, a metal oxide or a metal hydride |
05/17/1996 | WO1996014282A1 Polyol composition produced by co-spray-drying |
05/17/1996 | WO1996014199A1 Extrusion method |
05/17/1996 | WO1996014165A1 Polymerized phospholipid membrane mediated synthesis of metal nanoparticles |
05/17/1996 | WO1996014084A1 A storage stable water solution for infusion containing a thrombin inhibitor |
05/17/1996 | WO1996014083A1 Application of superoxide dismutase in liposomes |
05/17/1996 | WO1996014082A1 Methods and kits using macrophage stimulating protein |
05/17/1996 | WO1996014079A1 Novel cyclosporine preparation forms for oral administration of simple composition and high bio-availability, and process for producing them |
05/17/1996 | WO1996014074A1 Methods and devices for immunizing a host to tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides |
05/17/1996 | WO1996014070A1 Cisapride extended release oral compositions |
05/17/1996 | WO1996014069A1 Percutaneously absorbable patch |
05/17/1996 | WO1996014062A1 A delivery system for antimethanogenic agents |
05/17/1996 | WO1996014059A1 Pharmaceutical composition containing a fusible carrier and method for producing the same |
05/17/1996 | WO1996014058A1 Melt-extruded orally administrable opioid formulations |
05/17/1996 | WO1996014057A1 Tangential filtration preparation of liposomal drugs and liposome product thereof |
05/17/1996 | WO1996014056A1 Use of liquid fluorocarbons to facilitate pulmonary drug delivery |
05/17/1996 | WO1996014026A1 Analyte-controlled liquid delivery device and analyte monitor |
05/17/1996 | WO1996007398A3 Sustained release of peptides from pharmaceutical compositions |
05/17/1996 | CA2204398A1 Epoxy ester vesicles and paints |
05/17/1996 | CA2204370A1 Analyte-controlled liquid delivery device and analyte monitor |
05/17/1996 | CA2204358A1 A delivery system for antimethanogenic agents |
05/17/1996 | CA2203396A1 A storage stable water solution for infusion containing a thrombin inhibitor |
05/17/1996 | CA2203135A1 Use of liquid fluorocarbons to facilitate pulmonary drug delivery |
05/17/1996 | CA2180664A1 Polyol composition produced by co-spray-drying |
05/15/1996 | EP0711560A1 Pharmaceutical composition for the oral administration of flavonoids |
05/15/1996 | EP0711557A1 Base for formulating pharmaceutical agents |
05/15/1996 | EP0711556A1 Intravenous solutions containing staurosporine derivatives |
05/15/1996 | EP0711555A2 Enzyme inactivators |
05/15/1996 | EP0711551A2 Percutaneous absorption preparation |
05/15/1996 | EP0711550A1 Cyclosporin-containing soft capsule compositions |
05/15/1996 | EP0711549A2 Simulated capsule-like medicaments |
05/15/1996 | EP0711548A1 Injectable microdispersions for soft tissue repair and augmentation |
05/15/1996 | EP0711547A1 Delivery of controlled-release system(s) with shearform matrix |
05/15/1996 | EP0711546A1 Ophtalmic solution based on diclofenac and tobramicine and its applications |
05/15/1996 | EP0711544A2 Dentifrice composition |
05/15/1996 | EP0711540A1 Cosmetic or dermatologic oil/water dispersion stabilized with cubic gel particles and method of preparation |
05/15/1996 | EP0711539A1 Use of a salicylic acid derivative as stabilizer of oil-in-water emulsion, surfactants-free |
05/15/1996 | EP0711181A1 Psoriasis treatment |
05/15/1996 | EP0711175A1 Topical compositions for re-epitheliazation of persistent epithelial defects |
05/15/1996 | EP0711172A1 Compositions of crataegus species, medicaments and their use for preventing sudden death due to cardiac arrest and reperfusion-caused cardiovascular lesions |
05/15/1996 | EP0711171A1 Method for the improvement of wound healing and compositions therefor |
05/15/1996 | EP0711166A1 Controlled release tacrine drug delivery systems and methods for preparing same |
05/15/1996 | EP0711161A1 Method to inhibit restenosis |
05/15/1996 | EP0711158A1 Method of treating atherosclerosis or restenosis using microtubule stabilizing agent |
05/15/1996 | EP0711154A1 Stabilized pharmaceutical composition containing bupropion |
05/15/1996 | EP0711153A1 Transdermal delivery system package |
05/15/1996 | EP0711152A1 Powder-layered oral dosage forms |
05/15/1996 | EP0711151A1 Particles with modified physicochemical properties, their preparation and uses |
05/15/1996 | EP0711149A1 Liposomal antisense methyl phosphonate oligonucleotides and methods for their preparation and use |
05/15/1996 | EP0711148A1 Biphasic multilamellar lipid vesicles |
05/15/1996 | EP0711147A1 Suspensions for delivery of medicament |
05/15/1996 | EP0711146A1 Osmotic devices having vapor-permeable coatings |
05/15/1996 | EP0711142A1 Use of cross-linked copolymers of monoethylenically unsaturated carboxylic acids as stabilizers in oil-in-water emulsions |
05/15/1996 | EP0711140A1 Antifungal nail solution |
05/15/1996 | EP0711134A1 Medicinal for protection from neurological damage |
05/15/1996 | EP0711127A1 Methods of preparing gas-filled liposomes |
05/15/1996 | EP0682522B1 Process to prepare pharmaceutical compositions containing vecuronium bromide |
05/15/1996 | EP0641194B1 Oil-in-water emulsion containing a perfluoropolyether, composition comprising same, preparation method therefor and cosmeticological and dermatological use thereof |
05/15/1996 | EP0625898B1 Liposomal piroxicam formulations |
05/15/1996 | EP0620828A4 Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof. |
05/15/1996 | EP0615445B1 Pharmaceutically applicable nanosol and process for preparing the same |
05/15/1996 | EP0571513B1 Method of microencapsulation of hyperbaric gas |
05/15/1996 | EP0563389B1 Pharmaceutical aerosol preparation and its use for treatment and prophylaxis of viral diseases |
05/15/1996 | EP0551349B1 Transdermal device |
05/15/1996 | EP0493408B1 Oral anticoagulant/platelet inhibitor low dose formulation |
05/15/1996 | EP0462182B1 Matrix metalloproteinase peptides: role in diagnosis and therapy |
05/15/1996 | EP0458894B1 Lipid excipient for nasal delivery and topical application |
05/15/1996 | DE4440337A1 Pharmazeutische Nanosuspensionen zur Arzneistoffapplikation als Systeme mit erhöhter Sättigungslöslichkeit und Lösungsgeschwindigkeit Pharmaceutical nano-suspensions for drug administration than systems with increased saturation solubility and dissolution rate |
05/15/1996 | DE19536411A1 Adhesive salve for non-mycotic mucous membrane inflammation |
05/15/1996 | CN1122575A Stable liquid compositions of gamma interferon |
05/15/1996 | CN1122572A Aluminium containing pharmaceutical preparation with controlled release |
05/15/1996 | CN1122571A High dose formulations |
05/15/1996 | CN1122569A Transdermal therapeutic system containing estradiol |
05/15/1996 | CN1122565A Pour-on formulations containing polymeric material, glycols and glycerides |
05/15/1996 | CN1122241A Naomaitong injection for cerebral angiopathy |
05/15/1996 | CN1122237A Nose drops for rhinallergosis |
05/15/1996 | CN1122230A Compond sansheng pills |
05/15/1996 | CN1122229A Compound sansheng injection |
05/15/1996 | CN1122228A Chinese herbal medicinal bag for infantile diarrhea and malnutrition |
05/15/1996 | CN1122226A Tablet, capsule, or granule comprising desogestrel |
05/15/1996 | CN1122225A Ophthalmic suspension containing diflupredonate |
05/15/1996 | CN1122223A Preparing method for program-controlled skin permeable plaster |
05/15/1996 | CN1122222A Full-serial single Chinese herb medicine oral preparation |